These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Inhibition of pancreaticobiliary secretion by loperamide in humans. Thimister PW; Hopman WP; van Roermund RF; Willems HL; Rosenbusch G; Woestenborghs R; Jansen JB Hepatology; 1997 Aug; 26(2):256-61. PubMed ID: 9252131 [TBL] [Abstract][Full Text] [Related]
3. Suppression of vagus-mediated pancreatic polypeptide release by the mu-opiate receptor agonist loperamide in man. Riepl RL; Reichardt B; Auernhammer CJ; Beier G; Schopohl J; Stalla GK; Lehnert P Br J Clin Pharmacol; 1996 Sep; 42(3):371-7. PubMed ID: 8877029 [TBL] [Abstract][Full Text] [Related]
4. Effect of increasing oral doses of loperamide on gallbladder motility in man. Hopman WP; Rosenbusch G; Jansen JB; Lamers CB Br J Clin Pharmacol; 1990 Jan; 29(1):55-60. PubMed ID: 2297461 [TBL] [Abstract][Full Text] [Related]
5. M1 muscarinic mechanisms regulate intestinal-phase gallbladder physiology in humans. Nelson DK; Glasbrenner B; Dahmen G; Riepl RL; Malfertheiner P; Adler G Am J Physiol; 1996 Nov; 271(5 Pt 1):G824-30. PubMed ID: 8944697 [TBL] [Abstract][Full Text] [Related]
6. Effect of chlorpromazine (CPZ) on cholecystokinin-induced gallbladder contraction: the role of calcium. Pomeranz IS; Davison JS; Shaffer EA Isr J Med Sci; 1988 Jun; 24(6):275-81. PubMed ID: 2900226 [TBL] [Abstract][Full Text] [Related]
7. Effects of atropine, proglumide, and somatostatin analogue (SMS 201-995) on bombesin-induced gallbladder contraction and CCK secretion in humans. Mitsukawa T; Takemura J; Nishizono F; Nakatsuru K; Ohgo S; Matsukura S Am J Gastroenterol; 1989 Nov; 84(11):1371-4. PubMed ID: 2683738 [TBL] [Abstract][Full Text] [Related]
8. The basis for progesterone impairment of gallbladder contractility in male guinea pigs in vitro. Kiaii B; Xu QW; Shaffer EA J Surg Res; 1998 Oct; 79(2):97-102. PubMed ID: 9758722 [TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of cholecystokinin and cholecystokinin octapeptide on pancreatic secretion, gallbladder contraction, and plasma pancreatic polypeptide in man. Regan PT; Go VL; DiMagno EP J Lab Clin Med; 1980 Oct; 96(4):743-8. PubMed ID: 7419959 [TBL] [Abstract][Full Text] [Related]
10. Release of cholecystokinin and gallbladder contraction before and after gastrectomy. Inoue K; Fuchigami A; Hosotani R; Kogire M; Huang YS; Miyashita T; Suzuki T; Tsuda K; Seino Y; Rayford PL Ann Surg; 1987 Jan; 205(1):27-32. PubMed ID: 3800460 [TBL] [Abstract][Full Text] [Related]
11. Differences in cholecystokinin release and gallbladder contraction between emulsified and nonemulsified long-chain triglycerides. Ledeboer M; Masclee AA; Biemond I; Lamers CB JPEN J Parenter Enteral Nutr; 1999; 23(4):203-6. PubMed ID: 10421388 [TBL] [Abstract][Full Text] [Related]
12. Effect of aging on gallbladder contraction and release of cholecystokinin-33 in humans. Khalil T; Walker JP; Wiener I; Fagan CJ; Townsend CM; Greeley GH; Thompson JC Surgery; 1985 Sep; 98(3):423-9. PubMed ID: 4035564 [TBL] [Abstract][Full Text] [Related]
13. Postprandial release of cholecystokinin and pancreatic polypeptide in health and in gallstone disease: relationships with gallbladder contraction. Glasbrenner B; Domínguez-Muñoz JE; Nelson DK; Pieramico O; Holzwarth C; Riepl RL; Malfertheiner P Am J Gastroenterol; 1994 Mar; 89(3):404-10. PubMed ID: 8122654 [TBL] [Abstract][Full Text] [Related]
14. Effect of intraduodenal bile salt on pancreaticobiliary responses to bombesin and to cholecystokinin in humans. Thimister PW; Hopman WP; Tangerman A; Rosenbusch G; Willems HL; Jansen JB Hepatology; 1998 Dec; 28(6):1454-60. PubMed ID: 9828206 [TBL] [Abstract][Full Text] [Related]
15. Orlistat reduces gallbladder emptying by inhibition of CCK release in response to a test meal. Ellrichmann M; Ritter PR; Otte JM; Schrader H; Banasch M; Brunke G; Herzig KH; Seebeck J; Schmidt WE; Schmitz F Regul Pept; 2007 Mar; 139(1-3):136-40. PubMed ID: 17175037 [TBL] [Abstract][Full Text] [Related]
16. Role of CCK in regulation of pancreaticobiliary functions and GI motility in humans: effects of loxiglumide. Schmidt WE; Creutzfeldt W; Schleser A; Choudhury AR; Nustede R; Höcker M; Nitsche R; Sostmann H; Rovati LC; Fölsch UR Am J Physiol; 1991 Feb; 260(2 Pt 1):G197-206. PubMed ID: 1996640 [TBL] [Abstract][Full Text] [Related]
18. Stimulation of rainbow trout gallbladder contraction by cionin, an ancestral member of the CCK/gastrin family. Schjoldager B; Jørgensen JC; Johnsen AH Gen Comp Endocrinol; 1995 Jun; 98(3):269-78. PubMed ID: 7628686 [TBL] [Abstract][Full Text] [Related]
19. Modulation of gallbladder contraction by pirenzepine in humans. Yeğen B; Biren T; Onat F; Tankurt E; Gürmen N; Oktay S; Chey WY; Ulusoy NB Am J Gastroenterol; 1995 Sep; 90(9):1489-94. PubMed ID: 7661176 [TBL] [Abstract][Full Text] [Related]
20. Studies on neurotensin. I. Effects on gallbladder motility. Fujimura M Nihon Geka Hokan; 1989 Sep; 58(5):405-13. PubMed ID: 2642264 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]